Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856251) titled 'Lidocaine Infusions for Pain in Patients With Malignant Bowel Obstruction' on Sept. 28.
Study Type: Observational
Primary Sponsor: Fundación Santa Fe de Bogota
Condition:
Malignant Bowel Obstruction
Cancer Pain
Intestinal Obstruction
Intervention:
Drug: Lidocaine
Recruitment Status: Not recruiting
Date of First Enrollment: November 1, 2026
Target Sample Size: 50
To know more, visit https://clinicaltrials.gov/study/NCT07856251
Published by HT Digital Content Services with permission from Health Daily Digest....